Kingdon Capital Management, L.L.C. Argenx Se Transaction History

Kingdon Capital Management, L.L.C.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $7.1 Million - $9.79 Million	-27,889 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $7.59 Million - $9.85 Million	27,889 New	27,889 $9.77 Million
Q4 2019 Feb 14, 2020	SELL	$106.59 - $164.21 $19.7 Million - $30.3 Million	-184,631 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$113.31 - $150.51 $2.92 Million - $3.87 Million	-25,741 Reduced 12.24%	184,631 $21 Million
Q2 2019 Aug 14, 2019	SELL	$115.0 - $141.58 $6.92 Million - $8.52 Million	-60,176 Reduced 22.24%	210,372 $29.8 Million
Q1 2019 May 14, 2019	SELL	$98.85 - $134.59 $1.94 Million - $2.64 Million	-19,633 Reduced 6.77%	270,548 $33.8 Million
Q4 2018 Feb 14, 2019	BUY	$63.81 - $109.82 $1.33 Million - $2.29 Million	20,856 Added 7.74%	290,181 $27.9 Million
Q3 2018 Nov 14, 2018	BUY	$75.5 - $96.63 $5.06 Million - $6.48 Million	67,032 Added 33.14%	269,325 $20.4 Million
Q2 2018 Aug 14, 2018	BUY	$74.84 - $100.16 $2.72 Million - $3.63 Million	36,282 Added 21.86%	202,293 $16.8 Million
Q1 2018 May 15, 2018	BUY	$56.95 - $85.19 $4.43 Million - $6.62 Million	77,742 Added 88.07%	166,011 $13.4 Million
Q4 2017 Feb 14, 2018	BUY	$22.57 - $63.56 $1.99 Million - $5.61 Million	88,269	88,269 $5.57 Million

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.5B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.